125 related articles for article (PubMed ID: 33271963)
21. Fertility preservation by photodynamic therapy combined with conization in young patients with early stage cervical cancer: a pilot study.
Choi MC; Jung SG; Park H; Lee SY; Lee C; Hwang YY; Kim SJ
Photodiagnosis Photodyn Ther; 2014 Sep; 11(3):420-5. PubMed ID: 24927981
[TBL] [Abstract][Full Text] [Related]
22. Evaluating cervical neoplasia. LEEP as an alternative to cold knife conization.
Simmons JR; Anderson L; Hernandez E; Heller PB
J Reprod Med; 1998 Dec; 43(12):1007-13. PubMed ID: 9883402
[TBL] [Abstract][Full Text] [Related]
23. A randomized prospective study comparing three techniques of conization: cold knife, laser, and LEEP.
Mathevet P; Dargent D; Roy M; Beau G
Gynecol Oncol; 1994 Aug; 54(2):175-9. PubMed ID: 8063242
[TBL] [Abstract][Full Text] [Related]
24. Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect.
Han L; Zhang B
Infect Agent Cancer; 2023 Oct; 18(1):66. PubMed ID: 37898754
[TBL] [Abstract][Full Text] [Related]
25. HPV16 persistent infection and recurrent disease after LEEP.
Bruno MT; Cassaro N; Garofalo S; Boemi S
Virol J; 2019 Nov; 16(1):148. PubMed ID: 31775792
[TBL] [Abstract][Full Text] [Related]
26. The Quadrivalent Human Papillomavirus Vaccine in Recalcitrant Non-genital Warts: A Retrospective Study.
Kuan LY; Chua SH; Pan JY; Yew YW; Tan WP
Ann Acad Med Singap; 2020 Oct; 49(10):749-755. PubMed ID: 33283838
[TBL] [Abstract][Full Text] [Related]
27. Should the cervical dysplasia (CIN2+) recurrence nomogram be used for HPV vaccination triage after conization?
Tjalma WAA
Eur J Cancer Prev; 2021 Jan; 30(1):121. PubMed ID: 33273207
[No Abstract] [Full Text] [Related]
28. Usability Evaluation of the Novel Smartphone Application, HPV Vaccine: Same Way, Same Day, Among Pediatric Residents.
Real FJ; Rosen BL; Bishop JM; McDonald S; DeBlasio D; Kreps GL; Klein M; Kahn JA
Acad Pediatr; 2021; 21(4):742-749. PubMed ID: 33279739
[TBL] [Abstract][Full Text] [Related]
29. High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes.
Bogani G; Sopracordevole F; Di Donato V; Ciavattini A; Ghelardi A; Lopez S; Simoncini T; Plotti F; Casarin J; Serati M; Pinelli C; Valenti G; Bergamini A; Gardella B; Dell'acqua A; Monti E; Vercellini P; Fischetti M; D'ippolito G; Aguzzoli L; Mandato VD; Carunchio P; Carlinfante G; Giannella L; Scaffa C; Falcone F; Borghi C; Ditto A; Malzoni M; Giannini A; Salerno MG; Liberale V; Contino B; Donfrancesco C; Desiato M; Perrone AM; Dondi G; De Iaco P; Chiappa V; Ferrero S; Sarpietro G; Matarazzo MG; Cianci A; Bosio S; Ruisi S; Guerrisi R; Brusadelli C; Mosca L; Lagana' AS; Tinelli R; Signorelli M; De Vincenzo R; Zannoni GF; Ferrandina G; Lovati S; Petrillo M; Dessole S; Carlea A; Zullo F; Angioli R; Greggi S; Spinillo A; Ghezzi F; Colacurci N; Muzii L; Benedetti Panici P; Scambia G; Raspagliesi F
Gynecol Oncol; 2021 Apr; 161(1):173-178. PubMed ID: 33514481
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors for Non-Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA-Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine Trial.
Sierra MS; Tsang SH; Hu S; Porras C; Herrero R; Kreimer AR; Schussler J; Boland J; Wagner S; Cortes B; Rodríguez AC; Quint W; van Doorn LJ; Schiffman M; Sampson JN; Hildesheim A;
J Infect Dis; 2021 Aug; 224(3):503-516. PubMed ID: 33326576
[TBL] [Abstract][Full Text] [Related]
31. Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists.
Zacharia A; Harberts E; Valencia SM; Myers B; Sanders C; Jain A; Larson NR; Middaugh CR; Picking WD; Difilippantonio S; Kirnbauer R; Roden RB; Pinto LA; Shoemaker RH; Ernst RK; Marshall JD
Vaccine; 2021 Jan; 39(2):292-302. PubMed ID: 33309485
[TBL] [Abstract][Full Text] [Related]
32. Serum Anti-HPV Antibody Titer as a Marker of Vaccine Effectiveness in Males with Genital Infection.
De Toni L; Muscianisi F; Corsini C; Ghezzi M; Di Nisio A; Foresta C; Garolla A
Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33297367
[No Abstract] [Full Text] [Related]
33. Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse in HPV-Positive Women with Normal Cytology and Five-Year Type Concordance: A Randomized Comparison.
Inturrisi F; Bogaards JA; Heideman DAM; Meijer CJLM; Berkhof J
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):485-491. PubMed ID: 33293342
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs).
Naupu PN; van Zyl AR; Rybicki EP; Hitzeroth II
Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33291259
[TBL] [Abstract][Full Text] [Related]
35. Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study.
Cibula D; Dostalek L; Hillemanns P; Scambia G; Jarkovsky J; Persson J; Raspagliesi F; Novak Z; Jaeger A; Capilna ME; Weinberger V; Klat J; Schmidt RL; Lopez A; Scibilia G; Pareja R; Kucukmetin A; Kreitner L; El-Balat A; Pereira GJR; Laufhütte S; Isla-Ortiz D; Toptas T; Gil-Ibanez B; Vergote I; Runnenbaum I
Eur J Cancer; 2021 Jan; 143():88-100. PubMed ID: 33290995
[TBL] [Abstract][Full Text] [Related]
36. Hormonal Environment and HER2 Status in Extra-Mammary Paget's Disease (eMPD): A Systematic Literature Review and Meta-Analysis with Clinical Considerations.
Angelico G; Santoro A; Inzani F; Straccia P; Arciuolo D; Mulè A; Valente M; Spadola S; D'Alessandris N; Garganese G; Cianfrini F; Piermattei A; Scambia G; Zannoni GF
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33287150
[TBL] [Abstract][Full Text] [Related]
37. Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile.
Lorusso D; Maltese G; Sabatucci I; Cresta S; Matteo C; Ceruti T; D'Incalci M; Zucchetti M; Raspagliesi F; Sonetto C; Sinno V; Ronzulli D; Giolitto S; de Braud F
Target Oncol; 2021 Jan; 16(1):59-68. PubMed ID: 33369704
[TBL] [Abstract][Full Text] [Related]
38. Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan.
Baussano I; Sayinzoga F; Tshomo U; Tenet V; Vorsters A; Heideman DAM; Gheit T; Tommasino M; Umulisa MC; Franceschi S; Clifford GM
Emerg Infect Dis; 2021 Jan; 27(1):1-9. PubMed ID: 33350922
[TBL] [Abstract][Full Text] [Related]
39. Physicians' decision processes about the HPV vaccine: A qualitative study.
Bouchez M; Ward JK; Bocquier A; Benamouzig D; Peretti-Watel P; Seror V; Verger P
Vaccine; 2021 Jan; 39(3):521-528. PubMed ID: 33328141
[TBL] [Abstract][Full Text] [Related]
40. Human Papillomavirus Infections in Cervical Samples From HIV-Positive Women: Evaluation of the Presence of the Nonavalent HPV Genotypes and Genetic Diversity.
Sias C; Guarrasi V; Minosse C; Lapa D; Del Nonno F; Capobianchi MR; Garbuglia AR; Del Porto P; Paci P
Front Microbiol; 2020; 11():603657. PubMed ID: 33324386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
